Swecure Overview

  • Founded
  • 2013
Founded
  • Status
  • Out of Business
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Out of Business

Swecure General Information

Description

Developer of bacterial therapeutics treatments designed to treat immunoregulatory disorders, such as allergy and IBD. The company's treatments are based on extensive studies on the correlations between certain bacteria in the microbiome and disease development later in life, enabling people with immunoregulatory disorders to improve quality of life.

Contact Information

Website
www.swecure.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Primary Office
  • Stureplan 15
  • 111 45 Stockholm
  • Sweden
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Swecure Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2020 Completed Out of Business
2. Early Stage VC Completed Startup
1. Accelerator/Incubator Completed Startup
To view Swecure’s complete valuation and funding history, request access »

Swecure Patents

Swecure Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018521138-A Reduced risk of developing atopic dermatitis by using superantigen Pending 14-Jul-2015 0000000000
US-20180200358-A1 Reducing the risk of developing of atopic dermatitis by use of superantigen Abandoned 14-Jul-2015 0000000000
EP-3322440-A1 Reducing the risk of developing of atopic dermatitis by use of superantigen Granted 14-Jul-2015 0000000000
EP-3322440-B1 Reducing the risk of developing of atopic dermatitis by use of superantigen Active 14-Jul-2015 0000000000
US-20180028579-A1 Use of collinsella for treatment of inflammatory bowel disease Abandoned 12-Sep-2014 A61K35/741

Swecure Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial